Author: Healio ophthalmology

Portable artificial vision device may improve daily life for patients with low vision

CHICAGO — A new portable device from OrCam Technologies may provide advantages to subjects with low vision quality that other low vision aids cannot, according to a speaker here. “The OrCam is effective and can give these people increased functionality. This is very important for people who are missing out on a big part of their lives and miss it. It is very simple to understand, easy to use, reliable, highly portable and has at least some advantages over other low vision aids,” Elad Moisseiev, MD, said at a press (Read more...)

Alcon launches CyPass micro-stent at AAO meeting

CHICAGO — Alcon launched the CyPass micro-stent at the American Academy of Ophthalmology meeting, according to a company press release.CyPass, approved in July 2016 for use with cataract surgery to lower IOP in adult patients with mild to moderate primary open-angle glaucoma, is implanted during cataract surgery into the supraciliary space, the release said.

VIDEO: Thermal pulsation helps optimize ocular surface

CHICAGO — At the American Academy of Ophthalmology meeting here, Sumit “Sam” Garg, MD, discusses the preoperative assessment and treatment of the ocular surface prior to cataract surgery. In addition to re-esterified Omega-3 supplements and warm compress use, in many patients he finds the use of thermal pulsation of is a good option for creating an optimal ocular surface. 

MACRA rule may help ophthalmologists avoid penalties

CHICAGO — The recently finalized MACRA rule from the Centers for Medicare and Medicare Services may help ophthalmologists avoid penalties by shifting physician payments from a volume based payment program to a value based payment program, according to speakers here.“MACRA has established, really, an entirely new payment policy for physicians. They’re calling it a quality payment program. In a nutshell, they’re paying for value rather than volume…The final rule has been pretty encouraging in terms of what we believe is the ability for most of our members to avoid the (Read more...)

Adherence to Mediterranean diet can reduce risk of AMD

CHICAGO — Adherence to a Mediterranean-type diet, namely through increased consumption of fruits, can significantly reduce the risks of developing age-related macular degeneration, according to a speaker here. Joao Figueira, MD, PhD, reported results from the Coimbra Eye Study, a lifestyle and food habits questionnaire in the Portuguese population, at an American Academy of Ophthalmology press briefing here.

Three receive OWL awards

CHICAGO — Ophthalmic World Leaders, previously Ophthalmic Women Leaders, presented three OWL awards at its “signature event” during the American Academy of Ophthalmology meeting here.OWL, an organization dedicated to advancing diversity in leadership, gives the Rising Star Award, the Catalyst Award and the Visionary Award each year to a member of the organization.

Topical NSAID prevents pseudophakic CME in eyes with certain risk factors

CHICAGO — The use of once-daily 0.3% nepafenac after cataract surgery can help prevent pseudophakic cystoid macular edema in eyes with certain risk factors, but did not improve PCME outcomes in eyes without those risk factors, according to a presenter here. “We are able to show we had a significantly improved PCME outcome with risk factors. This is, in the general ophthalmology practice, about 10% to 30% of patients. However, in 70% to 90% of the patients, it is unlikely that clinical PCME outcomes are improved in those patients without (Read more...)

Visual gains achieved with abicipar for diabetic macular edema

CHICAGO — A cohort of patients with diabetic macular edema receiving abicipar pegol every 8 weeks showed “comparable” gains in visual acuity when compared with every 4-week dosing with ranibizumab, according to a presenter here. Tarek S. Hassan, MD, reported results of the PALM study at Retina Subspecialty Day preceding the American Academy of Ophthalmology meeting. In the multicenter, double masked, phase 2 trial supported by Allergan, 43 patients received 1 mg abicipar every 8 weeks, 41 patients received 2 mg abicipar every 8 weeks, 45 patients received 2 mg (Read more...)

IRIS becomes ‘world’s largest clinical registry’

CHICAGO — Since its debut on Jan. 1, 2013, the American Academy of Ophthalmology’s Intelligent Research in Sight Registry has become the world’s largest clinical registry, William L. Rich III, MD, said in a press briefing at the American Academy of Ophthalmology meeting.The registry provides ophthalmologists with data on more than 28 million U.S. patients and 100 million patient visits, according to Rich.